In the Media

Prof. James Collins and his colleagues are using AI to develop new antibiotic compounds to treat infections and combat antibiotic resistance concerns, reports Lisa M. Krieger for the San Fransico Chronicle. “Looking at the structure of a compound — bond by bond, substructure by substructure — it (AI) can make a calculation of the probability that it could be antibacterial,” explains Collins. So far, “Collins and his colleagues have synthesized several compounds that combat hard-to-treat infections of gonorrhea and MRSA,” writes Krieger. “These techniques are also being harnessed to fight diseases, like cancer, lupus and arthritis.”